In summary, 28.7% of CBS from neonates born to mothers with suspected past infection, had SARS-CoV-2 specific IgA or IgM antibodies suggesting in utero infection, with distinct variations in prevalence over the study period as new variants emerged. The gene discussed is CD79A; the disease is infection.